PI
ENFN

PEAK6 Investments’s Enfusion, Inc. ENFN Stock Holding History

PEAK6 Investments’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-70,291
Closed -$680K – 5092
2022
Q4 		$680K Buy
+70,291
New +$792K ﹤0.01% 2253

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

PEAK6 Investments's ENFN Position: Q1 2023 in Review

PEAK6 Investments sold out of Enfusion, Inc. (ENFN) in Q1 2023, closing a stake of 70,291 shares — an estimated $680K sold.

PEAK6 Investments first reported a position in ENFN in Q4 2022 and held it in 1 quarter. The position peaked at $680K in Q4 2022. 90 funds tracked by Wall St. Rank hold ENFN as of Q1 2023.

  • PEAK6 Investments reported no remaining Enfusion, Inc. position as of Q1 2023 after selling out during the quarter.
  • PEAK6 Investments sold 70,291 Enfusion, Inc. shares in Q1 2023, an estimated $680K.
  • PEAK6 Investments first reported a position in Enfusion, Inc. in Q4 2022 and held it in 1 quarter.
  • PEAK6 Investments's Enfusion, Inc. position peaked at $680K in Q4 2022.
  • 90 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2023.

Based on PEAK6 Investments's 13F filing for Q1 2023, filed 12 May 2023.